Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 26, 2026, Emergent BioSolutions Inc. (the "Company") issued a press release (the "Press Release") a
. Regulation FD Disclosure. On February 26, 2026, the Company will host a conference call to discuss its financial and operating results for the quarter and the
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Emergent BioSolutions Inc. on February 26, 2026. 99.2 Ea